These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8948410)

  • 1. Defining the role of surveillance in the management of localized prostate cancer.
    Palmer JS; Chodak GW
    Urol Clin North Am; 1996 Nov; 23(4):551-6. PubMed ID: 8948410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team.
    Fleming C; Wasson JH; Albertsen PC; Barry MJ; Wennberg JE
    JAMA; 1993 May; 269(20):2650-8. PubMed ID: 8487449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The comparative effectiveness of decision aids in diverse populations with early stage prostate cancer: a study protocol for a cluster-randomized controlled trial in the NCI Community Oncology Research Program (NCORP), Alliance A191402CD.
    Pacyna JE; Kim S; Yost K; Sedlacek H; Petereit D; Kaur J; Rapkin B; Grubb R; Paskett E; Chang GJ; Sloan J; Basch E; Major B; Novotny P; Taylor J; Buckner J; Parsons JK; Morris M; Tilburt JC
    BMC Cancer; 2018 Aug; 18(1):788. PubMed ID: 30081846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease.
    Van Den Eeden SK; Lu R; Zhang N; Quesenberry CP; Shan J; Han JS; Tsiatis AC; Leimpeter AD; Lawrence HJ; Febbo PG; Presti JC
    Eur Urol; 2018 Jan; 73(1):129-138. PubMed ID: 28988753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer and active surveillance.
    Abrahamsson PA
    Front Radiat Ther Oncol; 2008; 41():1-6. PubMed ID: 18544979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urologist-Level Correlation in the Use of Observation for Low- and High-Risk Prostate Cancer.
    Tyson MD; Graves AJ; O'Neil B; Barocas DA; Chang SS; Penson DF; Resnick MJ
    JAMA Surg; 2017 Jan; 152(1):27-34. PubMed ID: 27653425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Counseling the patient with localized prostate cancer.
    Montie JE
    Urology; 1994 Feb; 43(2 Suppl):36-40. PubMed ID: 8116131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Competitive morbidity ant its impact on life expectancy: evaluation and inclusion in the therapeutic decision regarding localized prostatic cancer].
    Soulié M; Villers A; Richaud P; Prapotnich D; Ruffion A; Grosclaude P
    Prog Urol; 2001 Dec; 11(6):1195-204. PubMed ID: 11859652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decision analysis using individual patient preferences to determine optimal treatment for localized prostate cancer.
    Sommers BD; Beard CJ; D'Amico AV; Dahl D; Kaplan I; Richie JP; Zeckhauser RJ
    Cancer; 2007 Nov; 110(10):2210-7. PubMed ID: 17893907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance.
    Goh AC; Kowalkowski MA; Bailey DE; Kazer MW; Knight SJ; Latini DM
    BJU Int; 2012 Jul; 110(2 Pt 2):E50-6. PubMed ID: 22145791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment options for localized prostate cancer.
    Mohan R; Schellhammer PF
    Am Fam Physician; 2011 Aug; 84(4):413-20. PubMed ID: 21842788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evaluation and treatment of men with asymptomatic prostate nodules in primary care: a decision analysis.
    Mold JW; Holtgrave DR; Bisonni RS; Marley DS; Wright RA; Spann SJ
    J Fam Pract; 1992 May; 34(5):561-8. PubMed ID: 1578205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Systematic Approach to Discussing Active Surveillance with Patients with Low-risk Prostate Cancer.
    Ehdaie B; Assel M; Benfante N; Malhotra D; Vickers A
    Eur Urol; 2017 Jun; 71(6):866-871. PubMed ID: 28129893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of localized prostatic cancer--different alternatives. Patients with localized prostatic cancer must actively participate in the choice of therapy].
    Adolfsson J
    Lakartidningen; 2000 Sep; 97(36):3870-4. PubMed ID: 11036336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Counseling patients about therapy for localized prostate cancer.
    Middleton RG
    Semin Urol Oncol; 1995 Aug; 13(3):187-90. PubMed ID: 8521131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel computer based expert decision making model for prostate cancer disease management.
    Richman MB; Forman EH; Bayazit Y; Einstein DB; Resnick MI; Stovsky MD
    J Urol; 2005 Dec; 174(6):2310-8. PubMed ID: 16280831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focal cryotherapy in the treatment of localized prostate cancer.
    Nguyen HD; Allen BJ; Pow-Sang JM
    Cancer Control; 2013 Jul; 20(3):177-80. PubMed ID: 23811701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of a CDC Public Health Research Agenda for Low-Risk Prostate Cancer.
    Hall IJ; Lee Smith J
    Am J Prev Med; 2015 Dec; 49(6 Suppl 5):S483-8. PubMed ID: 26590643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Describing perspectives of health care professionals on active surveillance for the management of prostate cancer.
    Pang K; Fitch M; Ouellet V; Chevalier S; Drachenberg DE; Finelli A; Lattouf JB; So A; Sutcliffe S; Tanguay S; Saad F; Mes-Masson AM
    BMC Health Serv Res; 2018 Jun; 18(1):430. PubMed ID: 29884180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.